Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles
Diossy, M.; Tisza, V.; Li, H.; Zhou, J.; Sztupinszki, Z.; Young, D.; Nousome, D.; Kuo, C.; Chen, Y.; Ebner, R.; Sesterhenn, I. A.; Moncur, J. T.; Chesnut, G. T.; Petrovics, G.; Klus, G. T.; Spisak, S.; Valcz, G.; Nuzzo, P. V.; Ribli, D.; Schina, A.; Borcsok, J.; Prosz, A.; Krzystanek, M.; Ried, T.; Szuts, D.; Kaochar, S.; Pathania, S.; D'Andrea, A. D.; Csabai, I.; Srivastava, S.; Dobi, A.; Freedman, M. L.; Szallasi, Z.
Show abstract
Chromodomain helicase DNA-binding protein 1 (CHD1) is frequently deleted in a subset of prostate cancers. We show here that subclonal deletion of CHD1 is nearly three times as frequent in prostate tumors of African American men than in men of European ancestry and it associates with rapid disease progression. We further show that CHD1 deletion is associated with only one type of the homologous recombination deficiency associated mutational signatures in prostate cancer. In prostate cancer cell line models CHD1 deletion did not induce HRD as detected by RAD51 foci formation assay, which was consistent with the moderate increase of olaparib sensitivity. CHD1 deficient prostate cancer cells, however, still showed markedly increased sensitivity to talazoparib, which could be effective for the treatment of CHD1 deficient tumors in the context of hormone therapy resistant prostate cancer.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bonemicroenvironment signatures 94%
- The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma 92%
- COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage 92%
Similar papers in this journal
Similar papers in this journal
- FOXP2 confers oncogenic effects in prostate cancer through activating MET signalling 95%
- Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study 93%
- Validation of a Multi-ancestry Polygenic Risk Score and Age-Specific Risks of Prostate Cancer: A Meta-analysis Within Diverse Populations 93%
Similar papers in this journal
- Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts Progression 93%
- Machine Learning-based Classification of transcriptome Signatures of non-ulcerative Bladder Pain Syndrome 91%
- Pro-apoptotic and anti-invasive properties underscore the tumor suppressing impact of myoglobin on subset of human breast cancer cells 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.